Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Chrysalis Initiative is a U.S.-based nonprofit health equity organization focused on reducing disparities in breast cancer care, particularly for Black women and other underserved groups. Founded in 2019 by Jamil Rivers, the organization provides one-on-one coaching, patient navigation, provider education, equity assessment, and digital support tools designed to improve care access and treatment experiences. Its BC Navi app supports patient education, care tracking, resource connection, and communication with oncology support teams. The organization also works with cancer centers and healthcare stakeholders on bias reduction, training, and systems-level interventions to improve breast cancer outcomes. While it operates in healthcare, it is not a drug-development biotech or pharmaceutical company and does not appear to have a therapeutic pipeline in the conventional sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Chrysalis Initiative.